NY Financial Regulator Files Insurance Fraud Charges Against Opioid Manufacturers

NY financial regulator files insurance fraud charges against opioid manufacturers

New York’s Department of Financial Services (DFS) has filed insurance fraud charges against opioid manufacturers Teva Pharmaceuticals and Allergan Plc.

According to a statement from Governor Andrew Cuomo, the DFS alleged in its filing that both Teva and Allergan took part in fraudulent marketing and promotional campaigns – campaigns which misrepresented the safety and effectiveness of opioid drugs.

Reuters reached out to both Teva and Allergan for comment, but neither were able to immediately respond.

Read more: Healthcare fraud tops $2 billion for tenth year in a row

In 2019, opioid manufacturer Insys Therapeutics paid $195 million to settle civil allegations that it gave kickbacks to physicians and nurses, bribing them to prescribe the company’s own drug Subsys for patients.

RECENT NEWS

The Fundamentals Of Asset-Liability Management

Author: Ricardo Goulart                           ... Read more

Enhancing Shareholder Value Through Fiscal Responsibility

Author: Brett Hurll                            &nb... Read more

The Importance Of Life Insurance In Financial Planning

Life is unpredictable, underscoring the cardinal rule within the realm of finances, "expect the unexpected.” Life insu... Read more

How Insurance Companies Determine Premiums

Decoding the labyrinth of how insurance companies determine premiums isn't as daunting as it seems. Essentially, insuran... Read more

Different Types Of Insurance And Their Benefits

Engaging with the intricate world of finance presents an age-old certainty - "Different types of insurance and their ben... Read more

Machine Learning In Risk Assessment For B2B Loans

Risky business, and even riskier decisions – that's where machine learning in risk assessment for B2B loans finds a pl... Read more